NIOIX | OSMAX | NIOIX / OSMAX | |
Total Expense Ratio | 1.06 | 1.37 | 77% |
Annual Report Gross Expense Ratio | 9.65 | 1.37 | 704% |
Fund Existence | 8 years | 27 years | - |
Gain YTD | -2.299 | 1.452 | -158% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6M | 3.24B | 0% |
Annual Yield % from dividends | 1.58 | 1.39 | 113% |
Returns for 1 year | -2.76 | -11.25 | 25% |
Returns for 3 years | -4.80 | -16.50 | 29% |
Returns for 5 years | 27.20 | -4.20 | -647% |
Returns for 10 years | N/A | 7.61 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PDECX | 14.31 | 0.56 | +4.07% |
PGIM Jennison Emerging Markets Eq Opps C | |||
SCVEX | 18.70 | 0.47 | +2.58% |
Hartford Schroders International Stk A | |||
TSOPX | 13.39 | 0.32 | +2.45% |
Nuveen International Res Eq Prmr | |||
DNLVX | 18.14 | 0.30 | +1.68% |
Dunham Large Cap Value N | |||
MSJIX | 15.46 | 0.15 | +0.98% |
Morgan Stanley Global Endurance I |